In a preclinical study involving a mouse model of myocardial infarction, MicroCures scientists demonstrated that animals treated with siFi2 experienced significant improvement in cardiac output at four weeks post treatment as compared to control (p = 0.0055).
Additional study findings demonstrated reduced ischemia and improved blood supply in animals treated with siFi2 as compared to control. Furthermore, siFi2-treated animals experienced regeneration of the mycocardium and vasculature in their infarcted hearts.